{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:54:41Z","timestamp":1790891681723,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Talanta"],"published-print":{"date-parts":[[2027,2]]},"DOI":"10.1016\/j.talanta.2026.130399","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T06:42:15Z","timestamp":1785825735000},"page":"130399","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"PA","title":["PET-modulated fluorescence enhancement of cabergoline: A DFT and time-resolved fluorescence guided analytical strategy"],"prefix":"10.1016","volume":"312","author":[{"given":"Abobakr A.","family":"Mohamed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Ibrahim","family":"Halawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Shahboub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3703-7221","authenticated-orcid":false,"given":"Islam M.","family":"Mostafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.talanta.2026.130399_bib1","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s12020-025-04176-0","article-title":"Etiology, presentation, and outcomes of hyperprolactinemia due to pituitary masses in children and adolescents","volume":"88","author":"Kilci","year":"2025","journal-title":"Endocrine"},{"key":"10.1016\/j.talanta.2026.130399_bib2","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s00431-025-06200-x","article-title":"Hyperprolactinemia in children and adolescents: clinical characteristics and etiological spectrum","volume":"184","author":"Kilci","year":"2025","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.talanta.2026.130399_bib3","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/s41574-023-00886-5","article-title":"Diagnosis and management of prolactin-secreting pituitary adenomas: a pituitary society international consensus statement","volume":"19","author":"Petersenn","year":"2023","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.talanta.2026.130399_bib4","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3109\/09513590.2015.1017810","article-title":"Hyperprolactinemia: pathophysiology and therapeutic approach","volume":"31","author":"Capozzi","year":"2015","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.talanta.2026.130399_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.arcmed.2024.103102","article-title":"Overview of hyperprolactinemia: general approach and reproductive health implications","volume":"55","author":"Haidenberg-David","year":"2024","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.talanta.2026.130399_bib6","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s11102-010-0290-z","article-title":"Cabergoline versus bromocriptine in the treatment of hyperprolactinemia: a systematic review of randomized controlled trials and meta-analysis","volume":"14","author":"dos Santos Nunes","year":"2011","journal-title":"Pituitary"},{"key":"10.1016\/j.talanta.2026.130399_bib7","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/ncpendmet0160","article-title":"Drug insight: Cabergoline and bromocriptine in the treatment of hyperprolactinemia in men and women","volume":"2","author":"Colao","year":"2006","journal-title":"Nat. Clin. Pract. Endocrinol. Metabol."},{"key":"10.1016\/j.talanta.2026.130399_bib8","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2165\/00003495-199549020-00009","article-title":"Cabergoline: a review of its pharmacological properties and therapeutic potential in the treatment of hyperprolactinaemia and inhibition of lactation","volume":"49","author":"Rains","year":"1995","journal-title":"Drugs"},{"key":"10.1016\/j.talanta.2026.130399_bib9","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1517\/14656566.1.3.555","article-title":"Cabergoline","volume":"1","author":"Colao","year":"2000","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.talanta.2026.130399_bib10","doi-asserted-by":"crossref","first-page":"633","DOI":"10.2165\/00003088-200342070-00003","article-title":"Clinical pharmacokinetics of cabergoline","volume":"42","author":"Del Dotto","year":"2003","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.talanta.2026.130399_bib11","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2165\/00003495-199855001-00002","article-title":"Pharmacodynamic and pharmacokinetic features of cabergoline: rationale for use in Parkinson's disease","volume":"55","author":"Fariello","year":"1998","journal-title":"Drugs"},{"key":"10.1016\/j.talanta.2026.130399_bib12","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1248\/cpb.55.629","article-title":"Spectrophotometric determination of dopaminergic drugs used for Parkinson's disease, cabergoline and ropinirole, in pharmaceutical preparations","volume":"55","author":"\u00d6nal","year":"2007","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.talanta.2026.130399_bib13","first-page":"304","article-title":"Spectrophotometric analysis of cabergoline in pharmaceutical preparations","volume":"30","author":"Salman","year":"2011","journal-title":"J. Liq. Chromatogr. Relat. Technol."},{"key":"10.1016\/j.talanta.2026.130399_bib14","first-page":"279","article-title":"Spectrophotometric determination of cabergoline in tablet dosage forms","volume":"5","author":"Rambabu","year":"2012","journal-title":"Asian J. Res. Chem."},{"key":"10.1016\/j.talanta.2026.130399_bib15","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1080\/10826076.2012.758142","article-title":"Hollow fiber liquid phase microextraction combined with high performance liquid chromatography for preconcentration and determination of cabergoline in biological samples","volume":"37","author":"Piroozi","year":"2014","journal-title":"J. Liq. Chromatogr. Relat. Technol."},{"key":"10.1016\/j.talanta.2026.130399_bib16","first-page":"437","article-title":"Preconcentration and determination of cabergoline using the green practical solvent bar liquid phase microextraction technique in biological fluids","volume":"14","author":"Farshad","year":"2018","journal-title":"Chem. Pap."},{"key":"10.1016\/j.talanta.2026.130399_bib17","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1007\/s10337-019-03763-4","article-title":"Development and validation of different chromatographic methods for analysis of cabergoline in the presence of its degradation products: studying degradation profile","volume":"82","author":"Farid","year":"2019","journal-title":"Chromatographia"},{"key":"10.1016\/j.talanta.2026.130399_bib18","first-page":"1","article-title":"Quantitative analysis and method validation of mirogabalin in postmortem blood and urine using liquid chromatography\u2013tandem mass spectrometry","author":"Yuyama","year":"2026","journal-title":"Forensic Toxicol."},{"key":"10.1016\/j.talanta.2026.130399_bib19","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1570-0232(03)00279-4","article-title":"Determination of cabergoline and L-dopa in human plasma using liquid chromatography\u2013tandem mass spectrometry","volume":"792","author":"Igarashi","year":"2003","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.talanta.2026.130399_bib20","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/(SICI)1097-0231(19980115)12:1<33::AID-RCM68>3.0.CO;2-U","article-title":"Quantitative determination of cabergoline in human plasma using liquid chromatography combined with tandem mass spectrometry","volume":"12","author":"Allievi","year":"1998","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.talanta.2026.130399_bib21","first-page":"132","article-title":"Method development and validation for the determination of cabergoline in tablets by capillary zone electrophoresis","volume":"30","author":"Dogan","year":"2011","journal-title":"J. Liq. Chromatogr. Relat. Technol."},{"key":"10.1016\/j.talanta.2026.130399_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2022.121639","article-title":"Spectrofluorimetric and stability-indicating thin layer chromatographic methods for determination of cabergoline, a prolactin inhibitor in pharmaceuticals","volume":"281","author":"Rizk","year":"2022","journal-title":"Spectrochim. Acta"},{"key":"10.1016\/j.talanta.2026.130399_bib23","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s10854-024-12909-6","article-title":"Electrochemical sensing platform based on two-dimensional Ni-MOF and ionic liquid modified carbon paste electrode for simultaneous determination of levodopa and cabergoline","volume":"35","author":"Mohammadipoor-Ghasemabad","year":"2024","journal-title":"J. Mater. Sci. Mater. Electron."},{"key":"10.1016\/j.talanta.2026.130399_bib24","first-page":"81","article-title":"Electrocatalytic determination of levodopa in presence of cabergoline using carbon paste electrode modified with graphene quantum dots\/2-chlorobenzoyl ferrocene\/ionic liquid","volume":"12","author":"Jahani","year":"2022","journal-title":"J. Electrochem. Sci. Eng."},{"key":"10.1016\/j.talanta.2026.130399_bib25","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1080\/00032719.2021.1880425","volume":"54","author":"Tajik","year":"2021","journal-title":"Anal. Lett."},{"key":"10.1016\/j.talanta.2026.130399_bib26","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.2174\/1573411016999200526130915","article-title":"A review of voltammetric methods for determination of dopamine agonists","volume":"17","author":"A\u011f\u0131n","year":"2021","journal-title":"Curr. Anal. Chem."},{"key":"10.1016\/j.talanta.2026.130399_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jelechem.2019.113223","article-title":"Disposable electrochemical sensor based on modified screen printed electrode for sensitive cabergoline quantification","volume":"847","author":"Mohammadi","year":"2019","journal-title":"J. Electroanal. Chem."},{"key":"10.1016\/j.talanta.2026.130399_bib28","first-page":"307","article-title":"Nano composite system based on ZnO-functionalized graphene oxide nanosheets for determination of cabergoline","volume":"8","author":"Beitollahi","year":"2017","journal-title":"J. Environ. Sci. Technol."},{"key":"10.1016\/j.talanta.2026.130399_bib29","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1134\/S1061934816030126","article-title":"Simple and low-cost electrochemical sensor based on nickel nanoparticles for the determination of cabergoline","volume":"71","author":"Fathi","year":"2016","journal-title":"J. Anal. Chem."},{"key":"10.1016\/j.talanta.2026.130399_bib30","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/elan.201300589","article-title":"First report for electrochemical determination of levodopa and cabergoline: application for determination of levodopa and cabergoline in human serum, urine and pharmaceutical formulations","volume":"26","author":"Tajik","year":"2014","journal-title":"Electroanalysis"},{"key":"10.1016\/j.talanta.2026.130399_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2025.344446","article-title":"Complexation-based spectrofluorimetric method for besifloxacin determination: combined experimental and computational insights","author":"Mohamed","year":"2025","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.talanta.2026.130399_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.microc.2025.113639","article-title":"Greenness, blueness, and whiteness evaluation of a density functional theory-validated photoinduced electron transfer deactivation protocol for sensitive fluorescence determination of butenafine","volume":"213","author":"Mostafa","year":"2025","journal-title":"Microchem. J."},{"key":"10.1016\/j.talanta.2026.130399_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.talanta.2017.01.033","article-title":"A novel and sensitive fluorescence sensor for glutathione detection by controlling the surface passivation degree of carbon quantum dots","volume":"166","author":"Pan","year":"2017","journal-title":"Talanta"},{"key":"10.1016\/j.talanta.2026.130399_bib34","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1021\/acs.accounts.6b00299","article-title":"Revising intramolecular photoinduced electron transfer (PET) from first-principles","volume":"49","author":"Escudero","year":"2016","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.talanta.2026.130399_bib35","series-title":"The United States Pharmacopeia (USP-NF)","first-page":"161","article-title":"Pharmacopeial methods and tests","author":"Sheinin","year":"2025"},{"key":"10.1016\/j.talanta.2026.130399_bib36","first-page":"1","article-title":"Recent advances in organic PET-based fluorometric chemosensors for the detection of Cu2+ ions","author":"Alosaimi","year":"2026","journal-title":"Chem. Rev. Anal. Chem."},{"key":"10.1016\/j.talanta.2026.130399_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.microc.2026.117577","article-title":"Fluorescence detection of furosemide for doping control in athletes: a DFT-supported approach for urine sample analysis","author":"Mohamed","year":"2026","journal-title":"Microchem. J."},{"key":"10.1016\/j.talanta.2026.130399_bib38","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1039\/D2CP05007B","article-title":"Interplay of conformational relaxation and hydrogen bond dynamics in the excited states of fluorescent Schiff base anions","volume":"25","author":"Dasgupta","year":"2023","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.talanta.2026.130399_bib39","series-title":"International Conference on Harmonization, Geneva","article-title":"Q2 (R1): validation of analytical procedures: text and methodology","year":"2005"},{"key":"10.1016\/j.talanta.2026.130399_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25322","article-title":"Cabergoline: a review of its use in the inhibition of lactation for women living with HIV","volume":"22","author":"Tulloch","year":"2019","journal-title":"J. Int. AIDS Soc."},{"key":"10.1016\/j.talanta.2026.130399_bib41","doi-asserted-by":"crossref","first-page":"10076","DOI":"10.1021\/acs.analchem.0c01887","article-title":"AGREE\u2014Analytical GREEnness metric approach and software","volume":"92","author":"Pena-Pereira","year":"2020","journal-title":"Anal. Chem."},{"key":"10.1016\/j.talanta.2026.130399_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.microc.2024.111078","article-title":"A fluorescence switch-off nanosensor for sensitive determination of the antiandrogen drug flutamide in pharmaceutical and environmental samples. Analytical method greenness, blueness, and whiteness assessment","volume":"204","author":"Abd-AlGhafar","year":"2024","journal-title":"Microchem. J."},{"key":"10.1016\/j.talanta.2026.130399_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.microc.2025.113034","article-title":"Integrating bio-based luminescent CQDs nanosensors and factorial-design-optimized sugaring-out homogenous liquid\u2013liquid Microextraction for sensitive determination of two neurologic drugs","volume":"210","author":"Abd-AlGhafar","year":"2025","journal-title":"Microchem. J."},{"key":"10.1016\/j.talanta.2026.130399_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.trac.2024.117895","article-title":"Lab-in-syringe as a practical technique for automatic microextraction: evaluation by blue applicability grade index","volume":"180","author":"Manousi","year":"2024","journal-title":"TrAC Trends Anal. Chem."},{"key":"10.1016\/j.talanta.2026.130399_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.trac.2023.117463","article-title":"Evaluating the whiteness of spectroscopy-based non-destructive analytical methods \u2013 application to food analytical control","volume":"170","author":"Jim\u00e9nez-Carvelo","year":"2024","journal-title":"TrAC Trends Anal. Chem."}],"container-title":["Talanta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039914026010556?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039914026010556?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:00:35Z","timestamp":1790888435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039914026010556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,2]]},"references-count":45,"alternative-id":["S0039914026010556"],"URL":"https:\/\/doi.org\/10.1016\/j.talanta.2026.130399","relation":{},"ISSN":["0039-9140"],"issn-type":[{"value":"0039-9140","type":"print"}],"subject":[],"published":{"date-parts":[[2027,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PET-modulated fluorescence enhancement of cabergoline: A DFT and time-resolved fluorescence guided analytical strategy","name":"articletitle","label":"Article Title"},{"value":"Talanta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.talanta.2026.130399","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130399"}}